We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$17.8B
AUM Growth
+$1.56B
Cap. Flow
+$1.29B
Cap. Flow %
7.26%
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Industrials 7.93%
3 Consumer Discretionary 7.91%
4 Financials 7.65%
5 Healthcare 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAERW icon
2026
Bridger Aerospace Warrant
BAERW
$10.9M
$6K ﹤0.01%
49,968
-1,618
-3% -$242
BGLC icon
2027
BioNexus Gene Lab
BGLC
$3.82M
$6K ﹤0.01%
1,467
-723
-33% -$4.06K
CISO
2028
CISO Global
CISO
$12.2M
$6K ﹤0.01%
+11,508
New +$10.9K
ENVB icon
2029
Enveric Biosciences
ENVB
$6.28M
$6K ﹤0.01%
61
-289
-83% -$43.6K
LZM.WS icon
2030
Lifezone Metals Ltd Warrants
LZM.WS
$27.4M
$6K ﹤0.01%
15,000
ROMA icon
2031
Roma Green Finance Ltd
ROMA
$529M
$6K ﹤0.01%
10,487
-24,262
-70% -$17.1K
WALDW icon
2032
Waldencast PLC Warrant
WALDW
$4.55M
$6K ﹤0.01%
24,970
XAIR icon
2033
Beyond Air
XAIR
$4.01M
$6K ﹤0.01%
+28
New +$13.9K
RRAC.WS
2034
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$6K ﹤0.01%
25,100
-100
-0.4% -$26
BFI
2035
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$6K ﹤0.01%
+33,324
New +$12.4K
KA
2036
DELISTED
Kineta, Inc. Common Stock
KA
$6K ﹤0.01%
+12,847
New +$6.72K
CAUD
2037
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$6K ﹤0.01%
12,860
-5,182
-29% -$2.55K
EFTR
2038
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$6K ﹤0.01%
+21,528
New +$51.1K
AEMD icon
2039
Aethlon Medical
AEMD
$1.59M
$5K ﹤0.01%
+25
New +$9.85K
GDHG icon
2040
Golden Heaven Group Holdings
GDHG
$79.1M
$5K ﹤0.01%
2
-1
-33% -$4.77K
NIOBW
2041
NioCorp Developments Ltd Warrant
NIOBW
$70.8M
$5K ﹤0.01%
24,975
PPBT
2042
Purple Biotech
PPBT
$1.31M
$5K ﹤0.01%
+69
New +$8K
SCLXW icon
2043
Scilex Holding Co Warrant
SCLXW
$2.77M
$5K ﹤0.01%
12,907
-10
-0.1% -$3
SDAWW
2044
SunCar Technology Group Warrant
SDAWW
$12.3M
$5K ﹤0.01%
30,940
PBM icon
2045
Psyence Biomedical
PBM
$13.3M
$5K ﹤0.01%
5
+2
+67% +$5.99K
GCTS.WS
2046
GCT Semiconductor Holding Warrants
GCTS.WS
$19.9M
$5K ﹤0.01%
33,466
+1
+0%
LUXH
2047
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$5K ﹤0.01%
+309
New +$13.7K
KRNLW
2048
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$5K ﹤0.01%
38,792
-11,523
-23% -$1.19K
ICUCW
2049
SeaStar Medical Holding Corp Warrant
ICUCW
$332K
$4K ﹤0.01%
74,280
-15,270
-17% -$1.26K
INM icon
2050
InMed Pharmaceuticals
INM
$7.64M
$4K ﹤0.01%
+800
New +$4.57K

Similar funds

HRT Financial's Q2 2024 Portfolio in Review

As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.

  • HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
  • HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
  • HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
  • HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
  • HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
  • HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
  • HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.